While the World Health Organization (WHO) has suspended the approval process of the Russian-developed Sputnik V COVID-19 vaccine, the Pan American Health Organization (PAHO) has chosen Argentina and Brazil to further manufacture mRNA immunizers.
Bolivian authorities Monday announced that with the last purchase of COVID-19 Sinopharm vaccines, the country was fully supplied with immunizers and would no longer need to import any more doses of Sputnik V and AstraZeneca despite contracts already signed.
Chile's Public Security Institute (ISP) Wednesday authorized the emergency use of the Russian anticoronavirus Sputnik V vaccine by 5 votes in favour, two abstentions and one against, it was announced.
Brazil's National Health Surveillance Agency (Anvisa) Friday approves, albeit with some restrictions, imports of Covaxin and Sputnik V doses for use in up to 1% of the country's population, it was announced.
Presidents Alberto Fernández of Argentina and Vladimir Putin of Russia are to launch Friday the beginning of local production at the South American country of the Sputnik V vaccine.
The Russian manufacturers of the Sputnik V vaccine have filed a libel lawsuit in Brazil against the country's National Health Surveillance Agency (Anvisa) for “intentionally spreading false and inaccurate information” about the covid-19 inoculator after prohibiting its import, citing lack of data, the immunizer's Twitter account (@sputnikvaccine) reported.
Brazil's National Health Surveillance Agency (Anvisa) Monday recommended against the import of the Russian-made Sputnik V vaccine to fight the covid-19 pandemic, citing lack of proper documents required for approval as well as other health risks the antidote may imply.
Brazil's National Health Surveillance Agency (Anvisa) will evaluate this coming week the feasibility of importing the Russian-manufactured Sputnik V vaccine against covid-19.
Argentine laboratory Richmond Tuesday delivered the first batch of locally-produced Sputnik V vaccines against covid-19 to be sent to Russia's Gamaleya Institute for final validation, it was announced.
While Argentina has already started trials to produce the Russian Sputnik V vaccine against covid-19, Brazil’s National Health Surveillance Agency (Anvisa) has filed a petition before the Federal Supreme Court (STF) for additional time to evaluate a registration request for the very same immunization shot.